A review of Perindopril in the reduction of cardiovascular events
Duncan J CampbellSt. Vincent’s Institute of Medical Research and the Department of Medicine, University of Melbourne, St. Vincent’s Hospital, Fitzroy, Victoria, AustraliaBackground: Angiotensin-converting enzyme inhibitors (ACEI) have a well-established role in the prevention of...
Main Author: | Duncan J Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2006-06-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/a-review-of-perindopril-in-the-reduction-of-cardiovascular-events-peer-reviewed-article-VHRM |
Similar Items
-
Perindopril for improving cardiovascular events
by: DiNicolantonio JJ, et al.
Published: (2014-08-01) -
Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril
by: Wang JG, et al.
Published: (2014-04-01) -
Perindopril in treatment of patients with arterial hypertension and high cardiovascular risk
by: Сергей Владимирович Недогода, et al.
Published: (2009-06-01) -
Comparative study of perindopril and perindopril metabolite pharmacokinetics using the HPLC/MS method
by: L. M. Krasnykh, et al.
Published: (2018-02-01) -
Perindopril/amlodipine-induced thrombotic microangiopathy
by: Vlatka Perisa, et al.
Published: (2021-01-01)